// App-Quantinova.ai

BSH19‐PO‐195 : T Cell Replete Haploidentical Transplantation for Haematological Malignancy; Experience from the Scottish Adult Allogeneic BMT Service

Researchers

Presenter

  • A. Kanny

Principal Investigators

  • V. Gibson

  • G. McQuaker

  • A. Parker

  • I. Novitzky-Basso

  • A.-L. Latif

  • K. Douglas

  • D. O'Brien

  • R. Boyd

  • D. Irvine

Medical Centers

  • NHS Greater Glasgow & Clyde, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Blood/haematological Diseases

Disease

  • Cytokine release syndrome

  • Thrombocytopenia

  • Graft-versus-host disease

  • Post-transplant lymphoproliferative disorder

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 34

  • Cluster of Differentiation 4

  • Twist-related protein 1

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Cyclosporine eent

  • Tocilizumab

  • Defibrotide

  • Eltrombopag

  • fludarabine tablet

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved